Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Revenue	0.02	0.02	0.03	15.23	1.06	1.57
Revenue Growth (YoY)	-99.85%	-14.81%	-99.82%	1335.16%	-32.20%	-88.06%
Gross Profit	0.02	0.02	0.03	15.23	1.06	1.57
Selling, General & Admin	8.86	8.58	5.11	7.02	3.69	3.79
Research & Development	10.53	15.56	20.17	14.54	9.49	6.48
Other Operating Expenses	0	0	0	0	0	0
Operating Expenses	19.39	24.15	25.28	21.56	13.18	10.26
Operating Income	-19.37	-24.12	-25.26	-6.33	-12.12	-8.7
Other Expense / Income	-3.4	-3.39	0.13	2.57	0.64	1.87
Pretax Income	-15.97	-20.74	-25.38	-8.9	-12.77	-10.57
Income Tax	-0.27	-0.27	-0.37	-0.48	-0.3	-0.3
Net Income	-15.7	-20.47	-25.01	-8.42	-12.47	-10.27
Shares Outstanding (Basic)	228	163	132	95	62	48
Shares Change	72.73%	23.78%	39.55%	52.17%	28.42%	0.17%
EPS (Basic)	-0.56	-1.12	-1.89	-0.72	-1.71	-1.79
EPS (Diluted)	-0.56	-1.12	-1.89	-0.72	-1.71	-1.79
Free Cash Flow	-12.68	-15.16	-22.76	-9.11	-8.81	-6.71
Free Cash Flow Per Share	-0.56	-0.93	-1.72	-0.96	-1.42	-1.39
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-84203.07%	-104886.96%	-93537.04%	-41.60%	-1142.60%	-555.65%
Profit Margin	-68256.84%	-88978.26%	-92644.44%	-55.30%	-1175.02%	-656.23%
Free Cash Flow Margin	-55138.99%	-65895.65%	-84303.70%	-59.83%	-830.35%	-429.01%
EBITDA	-	-18.87	-23.51	-7.64	-11.68	-9.48
EBITDA Margin	-	-82030.43%	-87085.19%	-50.17%	-1100.94%	-606.01%
Depreciation & Amortization	-	1.87	1.87	1.27	1.08	1.08
EBIT	-15.97	-20.74	-25.38	-8.9	-12.77	-10.57
EBIT Margin	-69434.84%	-90156.52%	-94007.41%	-58.48%	-1203.11%	-675.27%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).